GoHealth, Inc.
GoHealth, Inc. (GOCO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
goco · stock forecast · 10 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 10 Wall Street analysts in the past 3 months
Hold
10 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$5.00
Consensus
$5.00
+1215.8% upside
Low
$5.00
Median: $5 · Last Close: $0.38
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.38 | ↑ 0.00% |
1-day model range: $0.38–$0.38. Peak: $0.38 (+0.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · GOCO · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-26 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-11-20 | Freedom Broker | Maintains | Buy→Buy |
| 2025-11-19 | William Blair | Downgrade ↓ | Outperform→Market Perform |
| 2025-08-28 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2025-05-19 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2024-03-20 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2023-04-04 | Credit Suisse | Maintains | Underperform→Underperform |
| 2023-03-17 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2022-08-26 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2022-08-16 | Credit Suisse | Maintains | Underperform→Underperform |
Wall Street analysts have recently issued updated ratings on GoHealth, Inc. (GOCO) stock. Of the recent 35 rating actions, 0 were upgrades and 10 were downgrades. 10 analysts currently cover GOCO.
Analyst Recommendation Trends
GOCO analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$438M
↑ 17.7% YoY
Revenue Next Year
$224M
↓ 48.8% YoY
EPS This Year
$-20.39
EPS Next Year
$-7.47
↓ 63.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast GOCO EPS of $-20.39 for the current fiscal year, based on estimates from 5 analysts. The GOCO revenue forecast is $438M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The GOCO stock forecast is supported by two independent data sources: analyst consensus ratings from 10 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus GOCO price target is $5.00 (+1215.8% upside), with an analyst consensus of Hold.
The GOCO short-term stock prediction for tomorrow is $0.38 (+0.00%).
GoHealth, Inc. trades on NASDAQ under the ticker GOCO. The GOCO stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 10% of covering analysts.
Frequently asked questions
GOCO forecast · 8 questionsAccording to 10 Wall Street analysts, the average 12-month GOCO price target is $5.00, with a high forecast of $5.00 and a low of $5.00. The median price target is shown in the chart above when available. This implies +1215.8% potential upside from the current price of $0.38.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.